Instrumentation Section 

DOE Human Genome Program Contractor-Grantee Workshop VIII
February 27-March 2, 2000  Santa Fe, NM


Home
 
PDF

Author Index
Sequencing
Table of Contents
Abstracts   
Instrumentation
Table of Contents
Abstracts
Mapping 
Table of Contents
Abstracts
Bioinformatics
Table of Contents
Abstracts
Function and cDNA Resources
Table of Contents
Abstracts

Microbial Genome Program
Table of Contents
Abstracts
Ethical, Legal, and Social Issues
Table of Contents
Abstracts
Infrastructure
Table of Contents
Abstracts

Ordering Information

Abstracts from
Past Meetings

45. MicroArray of Gel Immobilized Compounds on Chip

V. Vasiliskov, A. Stomakhin, B. Strizhkov, S. Tillib, V. Mikhailovich, A. Sobolev, A. Kuhktin, and A. Mirzabekov

Joint Human Genome Program: Biochip Technology Center, Argonne National Laboratory, Argonne, IL 60439 and Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 117984

Micro Array of Gel Immobilized Compounds on a Chip (MAGIChipTM) are produced by immobilizing oligonucleotides1, DNA, enzymes, antibodies, and other proteins2 on a photopolymerized micromatrix of polyacrylamide gel pads. Recently, a photoco-polymerization technique was introduced for more rapid and inexpensive manufacturing of the microchips containing gel pads from 10´10´5 m to 100´100´20 m and larger in size3.

MAGIChips are efficient for carrying out direct hybridization tests, as well as for oligonucleotide ligation, single-base extension4, and PCR amplification of DNA. The fluorescence microscope has been devised for quantitative and real-time monitoring of hybridization, measuring the thermodynamic parameters of DNA duplexes, and measuring kinetics of enzymatic reaction on MAGIChips. On-chip MALDI-TOF mass spec-trometry was successfully tested for polymorphism analysis of DNA5. These technologies are demonstrated for identification of microorganisms, detection of their genes, and screening for mutations. Simple equipment and procedures have been developed for monitoring the hybridization of amplified DNA with oligonucleotide microchips and on-chip amplification. This allows us to carry out fast and inexpensive screening of Mycobacterium tuberculosis drug resistant mutations.

Work supported by the Department of Energy, Office of Health and Environmental Research under Contract No. W-31-109-ENG-38; Cooperative Research and Development Agreement No. 970192 between Argonne National Laboratory, Motorola, and Packard Instruments; Defense Advanced Research Project Agency under Interagency Agreement No. AO-E428; and the Russian Foundation of Fundamental Research under Grant 96-04-49858.

References

1. Yershov, G., Barsky, V., Belgovskiy, A., Kirillov, Eu., Kreindlin, E., Ivanov, I., Parinov, S., Guschin, D., Drobishev, Dubiley, S. & Mirzabekov, A. (1996) Proc. Natl. Acad. Sci. USA 93, 4913-4918.

2. Arenkov, P., Kuhktin, A., Gemmell, A., Chupeeva, V., & Mirzabekov, A. (2000) Anal. Biochem. (in press).

3. A. Vasiliskov, V., Timofeev E., Surzhikov S., Drobyshev, A., Shick, V., & Mirzabekov, A. BioTechnique 27, 592-606

4. Stomakhin, A, Vasiliskov, V., Timofeev, E., Schulga, D., Cotter, R., & Mirzabekov, A. (2000) Nucleic Acids Res. (in press).


The online presentation of this publication is a special feature of the Human Genome Project Information Web site.